Abstract
Microorganisms are an extremely promising alternative to the extended use of pesticides for bio-control of plants. Pesticides are often expensive and accumulate in plants, having adverse effects on humans. Moreover, detection of undesirable chemical compounds in the food chain connected with the emergence of fungicide-resistant strains of pathogens calls for an alternative, non-polluting strategy for controlling plant diseases. Thus, biological control through the use of natural antagonistic microorganisms has emerged, for a long time; gram-negative bacteria have been intensively investigated as biological control agents. However, recently the attention has switched to the gram-positive members of the aerobic, spore-forming genus Bacillus. Bacillus amyloliquefaciens is an important Bacillus species because of its ability to produce different bioactive compounds with a broad spectrum of activity. The endeavor of this article is to review the literature on the utilization of bioactive compounds from Bacillus amyloliquefaciens in bio-control.
Keywords: Antagonistic, Bacillus amyloliquefaciens, bio-control, bioactive compounds, pesticide, fungicide-resistant strains, pathogens Quorum sensing, Quorum sensing, autoinducers, PGPR
The Natural Products Journal
Title: Bioactive Compounds Hold Up- Bacillus amyloliquefaciens as a Potent Bio-Control Agent
Volume: 1 Issue: 1
Author(s): M. Balhara, S. Ruhil, Sandeep Dhankhar and A. K. Chhillar
Affiliation:
Keywords: Antagonistic, Bacillus amyloliquefaciens, bio-control, bioactive compounds, pesticide, fungicide-resistant strains, pathogens Quorum sensing, Quorum sensing, autoinducers, PGPR
Abstract: Microorganisms are an extremely promising alternative to the extended use of pesticides for bio-control of plants. Pesticides are often expensive and accumulate in plants, having adverse effects on humans. Moreover, detection of undesirable chemical compounds in the food chain connected with the emergence of fungicide-resistant strains of pathogens calls for an alternative, non-polluting strategy for controlling plant diseases. Thus, biological control through the use of natural antagonistic microorganisms has emerged, for a long time; gram-negative bacteria have been intensively investigated as biological control agents. However, recently the attention has switched to the gram-positive members of the aerobic, spore-forming genus Bacillus. Bacillus amyloliquefaciens is an important Bacillus species because of its ability to produce different bioactive compounds with a broad spectrum of activity. The endeavor of this article is to review the literature on the utilization of bioactive compounds from Bacillus amyloliquefaciens in bio-control.
Export Options
About this article
Cite this article as:
Balhara M., Ruhil S., Dhankhar Sandeep and K. Chhillar A., Bioactive Compounds Hold Up- Bacillus amyloliquefaciens as a Potent Bio-Control Agent, The Natural Products Journal 2011; 1 (1) . https://dx.doi.org/10.2174/2210315511101010020
DOI https://dx.doi.org/10.2174/2210315511101010020 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: Current Treatments for Skin Cancer Part 2)
Current Cancer Therapy Reviews Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy
Current Medicinal Chemistry Protein Kinases as Drug Targets in Human and Animal Diseases
Current Enzyme Inhibition The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Cardiovascular & Hematological Disorders-Drug Targets Antisense Oligonucleotides as an Innovative Therapeutic Strategy in the Treatment of High-Grade Gliomas
Recent Patents on CNS Drug Discovery (Discontinued) p53 as the Focus of Gene Therapy: Past, Present and Future
Current Drug Targets Elevated Expression of A-Raf and FA2H in Hepatocellular Carcinoma is Associated with Lipid Metabolism Dysregulation and Cancer Progression
Anti-Cancer Agents in Medicinal Chemistry Hydroxychloroquine (HCQ) and its Synthetic Precursors: A Review
Mini-Reviews in Organic Chemistry Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Meet Our Editorial Board Member:
Cardiovascular & Hematological Agents in Medicinal Chemistry Review of the Biological Activity of Maslinic Acid
Current Drug Targets Vitamin D Receptor Signaling and Pancreatic Cancer Cell EMT
Current Pharmaceutical Design The Role of Streptokinase as a Virulence Determinant of Streptococcus pyogenes – Potential for Therapeutic Targeting
Current Drug Targets Evolution of Molecular Targets in Melanoma Treatment
Current Pharmaceutical Design Gene Expression-Based Pharmacodynamic Biomarkers: The Beginning of a New Era in Biomarker-Driven Anti-Tumor Drug Development
Current Molecular Medicine Identification of Critical MicroRNA Gene Targets in Cervical Cancer Using Network Properties
MicroRNA Ellagic Acid Enhances the Efficacy of PI3K Inhibitor GDC-0941 in Breast Cancer Cells
Current Molecular Medicine Chemical Synthesis of Tea Polyphenols and Related Compounds
Current Pharmaceutical Design Role of Fc Receptors as a Therapeutic Target
Inflammation & Allergy - Drug Targets (Discontinued) Beneficial Effects of Plant Sources on the Treatment of Osteoporosis
Current Drug Targets